Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (2)
  • 2025 (6)
  • 2024 (3)
  • 2023 (3)
  • 2022 (1)
  • 2021 (1)
  • 2020 (1)

Subject

  • Drug Trafficking (132)
  • Synthetic drugs (125)
  • Arrests/Convictions - Major (54)
  • Guns/Weapons (37)
  • Prescription Drugs (35)
  • Seizures (Drugs/Property) (30)
  • Take Back Day (30)
  • Fake Pills (26)
  • Outreach/Drug Prevention (25)
  • Major Law Enforcement Operation (22)
  • Guilty Plea (21)
  • Public and Media Affairs - also see Congressional Affairs (18)
  • Pharmaceuticals/Pharmacists/Physicians (16)
  • Overdose (15)
  • OCDETF/Task Force (14)
  • Congressional Affairs (13)
  • Money Laundering (13)
  • Fentanyl Awareness (12)
  • Gangs (12)
  • Press Conferences (11)
  • Extraditions (10)
  • Red Ribbon (9)
  • One Pill Can Kill (8)
  • Prevention/Education - DEA websites GSAD, JTT etc (8)
  • Fentanyl Free America (7)
  • Task Forces/Task Force Officers (6)
  • Narcoterrorism (5)
  • Critical Incident (4)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Campaigns (3)
  • Counterfeit Pills (3)
  • Dark Web- Internet Trafficking (3)
  • Terrorism (3)
  • HIDTA (2)
  • Scam Calls (2)
  • Asset Forfeiture (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)
  • Diversion Division (17)

Drug Name

  • Methamphetamine (2)
  • Cocaine (1)
  • Fentanyl (1)
  • Heroin (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)
  • Opioids (1)
  • Oxycodone (1)
  • Synthetic Opioids (1)

Field Division

  • New England (35)
  • Washington, DC (34)
  • Seattle (25)
  • New York (23)
  • Chicago (18)
  • Houston (16)
  • New Jersey (14)
  • Atlanta (13)
  • Miami (10)
  • New Orleans (8)
  • El Paso (7)
  • St. Louis (7)
  • Dallas (5)
  • Rocky Mountain (5)
  • Phoenix (4)
  • Los Angeles (3)
  • Omaha (3)
  • San Diego (3)
  • Louisville (2)
  • Detroit (1)
  • Sede (10)
  • San Francisco (7)
Clear All Results
17 Results - Showing 1 to 10
PRESS RELEASE

DEA Operation Meltdown Shuts Down Hundreds of Illegal Online Pharmacies

WASHINGTON – Today, the U.S. Drug Enforcement Administration, with the cooperation of the U.S. Attorney’s Office for the Eastern District of New York, announced the seizure of more than 200 website domains tied to an India-based transnational criminal organization (TCO) working within the United States and allegedly responsible for at...
PRESS RELEASE

DEA Releases 2026 Aggregate Production Quotas

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

SAN FRANCISCO – United States Drug Enforcement Administration (“DEA”) San Francisco Division Special Agent in Charge Bob Beris, DEA New York Division Special Agent in Charge Frank Tarentino, along with our law enforcement partners Homeland Security Investigations (“HSI”) , U.S. Department of Health and Human Services – Office of Inspector...
PRESS RELEASE

Communities Nationwide Join DEA and its Partners to Safely Dispose of 571,000 pounds of Unwanted Medications

SAN FRANCISCO – On October 25, 2025, DEA joined 4,263 law enforcement agencies across the country who came together for the 29th National Prescription Drug Take Back Day. At 4,317 collection sites nationwide, Take Back events removed 571,054 pounds of unneeded and expired medications from home medicine cabinets to prevent...
PRESS RELEASE

Sacramento Doctor Agrees to Pay $125,000 for Controlled Substances Act Violations at Sutter Imaging Capitol Pavilion

SACRAMENTO, Calif. — Philip Yen, M.D. has agreed to pay the United States $125,000 to resolve allegations that he failed to comply with federal statutory requirements related to his role as the Drug Enforcement Administration registrant at Sutter Imaging Capitol Pavilion, Acting U.S. Attorney Michele Beckwith and Drug Enforcement Administration...
PRESS RELEASE

DEA Releases 2025 National Drug Threat Assessment

WASHINGTON – The U.S. Drug Enforcement Administration today announced the release of the 2025 National Drug Threat Assessment (NDTA), DEA’s comprehensive review of the threats posed to the United States by deadly illicit drugs and the violent domestic and international drug trafficking organizations responsible for producing and trafficking the drugs...
PRESS RELEASE

DEA Safely Disposes of 620,000 Pounds of Unused Medications on 28th National Prescription Drug Take Back Day

WASHINGTON – DEA and nearly 4,500 law enforcement agencies joined forces last month to dispose of more than 620,000 pounds of unneeded and expired medications in an effort to prevent drug misuse and abuse. The spring collection event marked DEA’s 28th National Prescription Drug Take Back Day. Since its inception...
PRESS RELEASE

Justice Department Sues Stockton-based Nurse Practitioner to Stop Her Sale of Illegal Opioid Prescriptions

SACRAMENTO, Calif. — The United States has filed a civil complaint against nurse practitioner Joan Rubinger, registered in Stockton, that alleges a long-running nationwide scheme to sell illegal opioid prescriptions for cash, Acting U.S. Attorney Michele Beckwith and Drug Enforcement Administration Special Agent in Charge Bob P. Beris announced. The...
PRESS RELEASE

DEA Issues Letter to E-Commerce Companies on the Sale of Pill Presses Used to Make Fentanyl Pills

WASHINGTON – The U.S. Drug Enforcement Administration today issued a letter to e-commerce companies regarding the sale of pill presses. As regulated entities under the Controlled Substances Act (CSA), e-commerce platforms are generally required to comply with CSA recordkeeping, identification, and reporting requirements on the distribution, importation, and exportation of...
PRESS RELEASE

DEA Announces Settlement with Morris & Dickson Co., LLC

WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...

Paginación

  • Current page 1
  • Page 2
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster